Causes and preventive measures of upper gastrointestinal bleeding in hyperbaric oxygen therapy for patients with severe closed craniocerebral injury
10.3969/j.issn.1005-1678.2017.06.145
- VernacularTitle:重型闭合性颅脑损伤高压氧治疗中并发上消化道出血的原因和预防措施
- Author:
Bin CHEN
;
Shenzhong QIU
;
Wen ZHANG
- Keywords:
severe closed craniocerebral injury;
hyperbaric oxygen therapy;
upper gastrointestinal hemorrhage
- From:
Chinese Journal of Biochemical Pharmaceutics
2017;37(6):380-382
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the causes and preventive measures of upper gastrointestinal bleeding in hyperbaric oxygen therapy for patients with severe closed head injury.MethodsThe clinical data of 24 cases of patients with upper gastrointestinal hemorrhage treated by hyperbaric oxygen therapy in the first people's Hospital of Fuyang District Hangzhou from May 2011 to May 2016 were analyzed, the occurrence time and clinical effect of upper gastrointestinal bleeding were analyzed.ResultsAmong the 24 cases of patients, 14 cases were treated for the first time that overt bleeding, including bleeding from the stomach liquid outflow of blood from 2 cases, gastric outflow 2 cases, hemorrhage after cure again received hyperbaric oxygen therapy 3 times again dominant bleeding 2 cases;6 cases hyperbaric oxygen treatment for third, 7, 10 times brown liquid or bloody fluid from the stomach outflow;4 cases hyperbaric oxygen treatment in patients with second and 3 courses of coffee liquid from the outflow tube, which accounted for 58.3%, 25.0%, 16.7% of the total, retrospectively;8 cases were with good recovery, 10 cases moderate disability, 4 cases severe disability, 2 cases vegetative state, 0 case died, the good recovery rate was 33.3%.ConclusionNot correctly grasp the time of hyperbaric oxygen therapy in the treatment of patients with severe closed craniocerebral injury will cause upper gastrointestinal hemorrhage, correct application of H2 receptor binding agent, developing targeted therapy programme can effectively prevent and treat upper gastrointestinal bleeding, so is worthy of the clinical's full attention.
